During the COVID-19 public health emergency, states used Appendix K, a standalone appendix available during emergency situations, to modify their existing Medicaid HCBS 1915(c) waiver programs. Using Appendix K, states can make to make temporary changes to access and eligibility, payment, services, and other aspects of their waiver programs.
Behavioral Health
Reports
Displaying 1 - 10 of 191. 10 per page. Page 1.
Advanced SearchReport
Emergency Department Interventions for Opioid Use Disorder
August 31, 2023
Emergency departments (EDs) are key partners in filling the gap between people who need opioid use disorder (OUD) treatment and people who ultimately receive it.
Research Brief
Early Changes in Waivered Clinicians and Utilization of Buprenorphine for Opioid Use Disorder After Implementation of the 2021 HHS Buprenorphine Practice Guidelines
December 2, 2022
In April 2021 the U.S. Department of Health and Human Services (HHS) issued revised Practice Guidelines for the Administration of Buprenorphine for Treating Opioid Use Disorder (Practice Guideline).
ASPE Issue Brief
National and State Estimates of Children Living with Parents Using Substances, 2015–2019
November 14, 2022
This brief presents estimates of the number and percentage of children whose parents engage in problematic substance use, including past-year substance use and SUD by substance type and child demographics. Key findings include:
Report
Certified Community Behavioral Health Clinics (CCBHC) Demonstration Program
November 3, 2022
Per Section 223(d)(7)(A) of the Protecting Access to Medicare Act (PAMA) of 2014 (Public Law 113-93), the HHS Secretary must submit to Congress an annual report on the use of funds provided under all demonstration programs conducted under this subsection, not later than one year after the date on which the first state is selected for a demonstration program under this subsection, and annually t
ASPE Issue Brief, Database, Dataset
Flexibilities in Controlled Substances Prescribing and Dispensing During the COVID-19 Pandemic
September 8, 2022
The COVID-19 pandemic had wide-ranging impacts on health care delivery, particularly services that require in-person interactions. For patients needing access to medications to treat pain or certain substance use disorders, the COVID-19 pandemic presented particular challenges for continuity of treatment.
Environmental Scan
Continuity of Care Services Following Coordinated Specialty Care: An Environmental Scan
May 2, 2022
This report provides an overview of transition services for clients graduating from Coordinated Specialty Care (CSC). CSC Programs have been successfully implemented across the US, including through support from the Community Mental Health Services Block Grant set aside funds for people with early psychosis.
ASPE Issue Brief
Transition Options, Opportunities for Integration, and Funding Considerations Following Coordinated Specialty Care Issue Brief
May 2, 2022
This brief is the third publication from the Continuity of Care Services Following Coordinated Specialty Care study. It provides a short overview of the different approaches to continuity of care for young adults who have attended CSC programs and explores avenues for integration within programs and organizations as a way to support young adults following a completion of a CSC program.
Report
The Coordinated Specialty Care Transition Study: Final Report
May 2, 2022
The Coordinated Specialty Care Transition Study: Final Report provides an overview of transition services for clients graduating from Coordinated Specialty Care (CSC). This the second publication from the Continuity of Care Services Following Coordinated Specialty Care study.
Report
State Residential Treatment for Behavioral Health Conditions: Regulation and Policy
April 30, 2021
ABSTRACT: Residential treatment facilities are a key component of states' behavioral health systems. They form part of the spectrum of treatment for both mental and substance use disorders (M/SUDs).